The G-cide complex has eliminated many of the safety issues of glutaraldehyde such as skin irritation, corrosion, sensitisation and potential respiratory problems
A 'revolutionary' new disinfectant being launched onto the worldwide market will have far reaching benefits across a number of industries, says its maker.
GX+ with G-cide contains the G-cide complex that allows glutaraldehyde to be used in a safer and more environmentally friendly way while enhancing its efficacy.
GX+ with G-cide is set to revolutionise infection control, says GX Laboratories.
GX+ products contain the active ingredient G-cide (Inci name Glutaral C11-C15 Pareth 9) a new complex which is able to kill 99.9% of bacteria, viruses, fungi and spores in a much shorter time and similar concentrations than existing products.
G-cide is currently unrivalled in efficacy and safety by existing products of a similar type, says GX.
The award-winning G-cide complex was created by South African scientist Toni Martin.
Toni Martin used the chemical glutaraldehyde and stabilised it by complexing it with a large molecular non-ionic surfactant.
The G-cide complex has eliminated many of the safety issues of glutaraldehyde such as skin irritation, corrosion, sensitisation and potential respiratory problems.
Glutaraldehyde at near neutral pH is only stable for a limited amount of time (14-28 days), whereas the G-cide complex is near neutral pH and can be safely stored for at least 12 months without reducing its efficacy.
GX laboratories has also established a strategic alliance with Dow Biocides for the exclusive supply of the highest quality glutaraldehyde from the world's leading supplier.
G-cide based products have positive implications for the agricultural and livestock sectors, helping prevent the spread of contact transmitted diseases such as foot and mouth and avian influenza.
The broad kill spectrum of GX+ with G-cide is also beneficial to the food industry, for transport as well as having the potential to seriously reduce a majority of hospital acquired infections.
The first range of GX+ products to become available will be a range of hand sanitisers, for use by medical staff.
The antimicrobial hand sanitiser, hand soap and moisturising creams are water based and, unlike existing products, are non-irritant and will not dry out the skin.
Hospital staff can use them frequently throughout the day without encountering the painful skin problems which have left many doctors and nurses understandably reluctant to sanitise their hands between patients.
The quick drying and non-greasy GX+ hand product range is also effective against the most serious pathogens and as a contact disinfectant, has a residual killing power that will help stop the transition of infection from patient to patient.
